Perioperative IV Dexamethasone Decreased Opioid Consumption After Total Knee Arthroplasty
The perioperative administration of IV dexamethasone should be considered as part of a multimodal analgesic regimen for total knee arthroplasty.
The perioperative administration of IV dexamethasone should be considered as part of a multimodal analgesic regimen for total knee arthroplasty.
In a double-blind, placebo-controlled study, researchers evaluated the effects of a novel depot bupivacaine formulation on postoperative pain after subacromial decompression.
Comparable pain outcomes were found after mechanochemical ablation and cyanoacrylate adhesive injections for primary saphenous vein incompetence.
Patients undergoing lumbar spinal fusion surgery who were cannabis users consumed more opioids both prior to and after hospital discharge.
The provision of multimodal nonopioid analgesia was linked to reduced subacute pain after total knee and hip arthroplasty.
This study evaluated patterns of prehospital pain management utilized by emergency medical services across the United States.
Needle electrical twitch intramuscular targeting the retracted intercostal muscles reduced pain after thoracotomy.
Polygenic risk scores for advanced knee and hip osteoarthritis are associated with the risk for knee and hip replacements.
The FDA has expressed serious concerns related to the potential health effects for patients who have consumed delta-8 THC products.
Local effects of topical CBD may not provide additional pain relief after knee arthroplasty.